Nutriband Inc. (NASDAQ:NTRBW – Get Free Report) shares traded down 10.7% on Tuesday . The company traded as low as $1.59 and last traded at $1.59. 4,049 shares changed hands during mid-day trading, a decline of 78% from the average session volume of 18,134 shares. The stock had previously closed at $1.78.
Nutriband Trading Down 10.7 %
The company’s 50 day moving average price is $1.75 and its 200-day moving average price is $1.50.
Institutional Investors Weigh In On Nutriband
A hedge fund recently raised its stake in Nutriband stock. Citadel Advisors LLC lifted its position in shares of Nutriband Inc. (NASDAQ:NTRBW – Free Report) by 8.4% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 126,392 shares of the company’s stock after purchasing an additional 9,801 shares during the quarter. Citadel Advisors LLC’s holdings in Nutriband were worth $190,000 as of its most recent filing with the SEC.
About Nutriband
Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy.
Recommended Stories
- Five stocks we like better than Nutriband
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Hims & Hers Earnings Could Be a Game Changer—What to Do Now
- How to Use the MarketBeat Dividend Calculator
- DeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI Stocks
- 3 Best Fintech Stocks for a Portfolio Boost
- Mortgage Market Bottom? Why Rocket Companies Could Be a Buy
Receive News & Ratings for Nutriband Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutriband and related companies with MarketBeat.com's FREE daily email newsletter.